Recent News

15Jul, 2016

Testosterone: Friend or Foe?

By: | Tags:

Testosterone: Friend or Foe? MICHAEL DATTOLI, MD & GINYA CARNAHAN, APR, CRPC Perhaps one of the most controversial subjects in the prostate cancer world is the role of testosterone – its influence on the development of prostate cancer, its impact on current tumor growth, and more recently its possible ability to slow the growth of prostate cancer. As a clinic that specializes in, and has treated thousands of prostate cancer patients in our 26 years of operation (Tampa & Sarasota), Dattoli Cancer Center has seen this issue more times than […]
READ MORE

26Feb, 2015

ASCO Genitourinary Cancer Symposium February 2015

By: | Tags:

This is a poster presentation on the Advantages of 3D Color Flow Doppler Ultrasound Guided Biopsies. Dattoli, M., Sorace, R., Bravo, S., Bostwick, D.; Prostate biopsies using both gray scale and 3D color flow power Doppler ultrasound (3DCFPDU). ASCO-GU, 14100 February 2015  
READ MORE

21Nov, 2014

DATTOLI CENTER OFFERS NEW THERAPEUTIC AGENT FOR ADVANCED METASTATIC PROSTATE CANCER

By: | Tags:

(June 10, 2014 – Sarasota, FL)  This week Dattoli Cancer Center & Brachytherapy Research Institute became the first independent physician practice in the U.S. to offer men with advanced metastatic prostate cancer an injectable isotope of radium, marketed by Bayer as Xofigo® (zoh-fee-go).  This new pharmaceutical was recently FDA approved for use in men with castration-resistant prostate cancer (CRPC), which means their cancer has spread to bones. Consisting of Radium Ra 223 dichloride, the drug is administered as an injection once a month, for 6 treatments.  Xofigo® reacts similarly to […]
READ MORE

18Jun, 2010

New Ultrasound Technology Debuts at Dattoli Cancer Center

By: | Tags:

(June 18, 2010 – Sarasota, FL) Dattoli Cancer Center has invested in the newest color-flow Doppler ultrasound technology for its prostate cancer treatment center and brachytherapy (seed implant) suite. The Hitachi “HI VISION 900” is the latest generation premium class, high-resolution ultrasound system representing a genuine advance in image quality and clinical utility. The equipment brings a new level of enhanced visualization through real-time elastography – technology that has been identified to distinguish the most subtle tissue differences, critically important in delineating cancerous and benign tissue using tissue gradients. Among […]
READ MORE

7Jun, 2010

Dattoli Cancer Center CT Lab ICACTL-Accredited

By: | Tags:

(June 7, 2010 – Sarasota, FL) The computed tomography laboratory at Dattoli Cancer Center & Brachytherapy Research Institute has been notified that it has been granted accreditation by the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories (ICACTL). The laboratory, supervised by Donald Bryant, R.T.(R)(T)(C) ARRT, under the direction of Michael Dattoli, MD, is one of the first 500 laboratories world-wide to achieve this stringent accreditation status. There are estimated to be 62 million CT scans performed in the US each year. CT is a complex imaging technique that […]
READ MORE

5Apr, 2010

Dattoli Participates in Mount Sinai

By: | Tags:

DATTOLI PARTICIPATES IN MOUNT SINAI RUDIN-KASE DEAN’S LECTURE SERIES (April 5, 2010 – Sarasota, FL) Dr. Michael Dattoli, founder and physician-in-chief of the Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota, has just returned from speaking to a group of physicians at Mount Sinai School of Medicine in New York City. Dattoli participated in the Rudin-Kase Dean’s Lecture Series, which is held to update current faculty on the leading-edge work of its outstanding alumni. A graduate of the esteemed medical school, radiation oncologist Dattoli has concentrated on non-surgical approaches […]
READ MORE

3Mar, 2010

Complex New Guidelines

By: | Tags:

Complex New Guidelines From Multiple Organizations Confuses Men About Prostate Cancer Screening WASHINGTON, March 3 /PRNewswire-USNewswire/ — Members of America’s Prostate Cancer Organizations are concerned that the issuance this morning of yet another set of new guidelines on screening for prostate cancer is only adding to the confusion most men already feel about whether they should or shouldn’t be tested for the most common form of cancer in American men. “It is time for us all to come together and make one, straightforward recommendation about screening and early detection of […]
READ MORE

2Mar, 2010

Ignorance is Bliss When it Comes to Prostate Cancer

By: | Tags:

American Cancer Society: Ignorance is Bliss When it Comes to Prostate Cancer By Rick Lyke The American Cancer Society is telling men to pull up their pants, roll down their sleeves and not to worry about that prostate cancer thing. In a guidance issued on Wednesday, the group – which carries a huge amount of weight with physicians and patients – basically said American men are better off not knowing if they have prostate cancer. Citing difficulties in determining who should be treated when cancer is found, the American Cancer […]
READ MORE

'

Call 1-877-DATTOLI or Send Us a Message Now